129 related articles for article (PubMed ID: 34275248)
21. Natural killer cell activity and function in chronic HCV-infected patients during peg interferon and ribavirin: early effects of active substance use.
Hotho DM; Kreefft K; Groothuismink ZM; Janssen HL; de Knegt RJ; Boonstra A
Antiviral Res; 2013 Mar; 97(3):347-55. PubMed ID: 23291200
[TBL] [Abstract][Full Text] [Related]
22. Changes of natural killer cells' phenotype in patients with chronic hepatitis B in intermittent interferon therapy.
Bi X; Xie S; Wu S; Cao W; Lin Y; Yang L; Jiang T; Deng W; Wang S; Liu R; Gao Y; Shen G; Chang M; Hao H; Xu M; Chen X; Hu L; Lu Y; Zhang L; Xie Y; Li M
Front Immunol; 2023; 14():1116689. PubMed ID: 36793722
[TBL] [Abstract][Full Text] [Related]
23. Hepatitis C Virus-Induced Myeloid-Derived Suppressor Cells Suppress NK Cell IFN-γ Production by Altering Cellular Metabolism via Arginase-1.
Goh CC; Roggerson KM; Lee HC; Golden-Mason L; Rosen HR; Hahn YS
J Immunol; 2016 Mar; 196(5):2283-92. PubMed ID: 26826241
[TBL] [Abstract][Full Text] [Related]
24. CD3(+)CD56(+) Natural Killer-Like T Cells Display Anti-HCV Activity but Are Functionally Impaired in HIV(+) Patients With Acute Hepatitis C.
Kokordelis P; Krämer B; Boesecke C; Voigt E; Ingiliz P; Glässner A; Wolter F; Srassburg CP; Spengler U; Rockstroh JK; Nattermann J
J Acquir Immune Defic Syndr; 2015 Dec; 70(4):338-46. PubMed ID: 26509931
[TBL] [Abstract][Full Text] [Related]
25. Effect of Antiviral Therapy During Pregnancy on Natural Killer Cells in Pregnant Women With Chronic HBV Infection.
Wang F; Xie S; Ran C; Hao H; Jiang T; Deng W; Bi X; Lin Y; Yang L; Sun F; Zeng Z; Xie Y; Li M; Yi W
Front Immunol; 2022; 13():893628. PubMed ID: 35677040
[TBL] [Abstract][Full Text] [Related]
26. CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection.
Lin AW; Gonzalez SA; Cunningham-Rundles S; Dorante G; Marshall S; Tignor A; Ha C; Jacobson IM; Talal AH
Clin Exp Immunol; 2004 Aug; 137(2):408-16. PubMed ID: 15270860
[TBL] [Abstract][Full Text] [Related]
27. Interferon-alpha-induced TRAIL on natural killer cells is associated with control of hepatitis C virus infection.
Stegmann KA; Björkström NK; Veber H; Ciesek S; Riese P; Wiegand J; Hadem J; Suneetha PV; Jaroszewicz J; Wang C; Schlaphoff V; Fytili P; Cornberg M; Manns MP; Geffers R; Pietschmann T; Guzmán CA; Ljunggren HG; Wedemeyer H
Gastroenterology; 2010 May; 138(5):1885-97. PubMed ID: 20334827
[TBL] [Abstract][Full Text] [Related]
28. Polarization of granulocytic myeloid-derived suppressor cells by hepatitis C core protein is mediated via IL-10/STAT3 signalling.
Wang M; Ping Y; Li Z; Li J; Zhang Z; Yue D; Chen X; Wang L; Huang L; Huang J; Yang L; Zhao X; Yang S; Li H; Shi J; Li J; Zhang Y
J Viral Hepat; 2019 Feb; 26(2):246-257. PubMed ID: 30339295
[TBL] [Abstract][Full Text] [Related]
29. Interferon therapy shifts natural killer subsets among Egyptian patients with chronic hepatitis C.
Fathy A; Eldin MM; Metwally L; Eida M; Abdel-Rehim M; Esmat G
Braz J Infect Dis; 2010; 14(4):398-405. PubMed ID: 20963327
[TBL] [Abstract][Full Text] [Related]
30. Immunological Analysis During Interferon-Free Therapy for Chronic Hepatitis C Virus Infection Reveals Modulation of the Natural Killer Cell Compartment.
Spaan M; van Oord G; Kreefft K; Hou J; Hansen BE; Janssen HL; de Knegt RJ; Boonstra A
J Infect Dis; 2016 Jan; 213(2):216-23. PubMed ID: 26223768
[TBL] [Abstract][Full Text] [Related]
31. Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection.
Miyagi T; Takehara T; Nishio K; Shimizu S; Kohga K; Li W; Tatsumi T; Hiramatsu N; Kanto T; Hayashi N
J Hepatol; 2010 Sep; 53(3):424-30. PubMed ID: 20554341
[TBL] [Abstract][Full Text] [Related]
32. Imbalance between CD56+bright and CD56+dim natural killer cell subsets in the liver of patients with recurrent hepatitis C after liver transplantation.
Yamagiwa S; Sato Y; Ichida T; Setsu T; Tominaga K; Kamimura H; Tsuchiya A; Takamura M; Matsuda Y; Aoyagi Y
Biomed Res; 2014; 35(3):177-84. PubMed ID: 24942856
[TBL] [Abstract][Full Text] [Related]
33. Natural killer p46High expression defines a natural killer cell subset that is potentially involved in control of hepatitis C virus replication and modulation of liver fibrosis.
Krämer B; Körner C; Kebschull M; Glässner A; Eisenhardt M; Nischalke HD; Alexander M; Sauerbruch T; Spengler U; Nattermann J
Hepatology; 2012 Oct; 56(4):1201-13. PubMed ID: 22532190
[TBL] [Abstract][Full Text] [Related]
34. Frequencies of Circulating MAIT Cells Are Diminished in Chronic HCV, HIV and HCV/HIV Co-Infection and Do Not Recover during Therapy.
Spaan M; Hullegie SJ; Beudeker BJ; Kreefft K; van Oord GW; Groothuismink ZM; van Tilborg M; Rijnders B; de Knegt RJ; Claassen MA; Boonstra A
PLoS One; 2016; 11(7):e0159243. PubMed ID: 27416100
[TBL] [Abstract][Full Text] [Related]
35. Decrease in CD3-negative-CD8dim(+) and Vdelta2/Vgamma9 TcR+ peripheral blood lymphocyte counts, low perforin expression and the impairment of natural killer cell activity is associated with chronic hepatitis C virus infection.
Pár G; Rukavina D; Podack ER; Horányi M; Szekeres-Barthó J; Hegedüs G; Paál M; Szereday L; Mózsik G; Pár A
J Hepatol; 2002 Oct; 37(4):514-22. PubMed ID: 12217606
[TBL] [Abstract][Full Text] [Related]
36. [Phenotype and functions of natural killer cells in septic patients and its clinical significance].
Pan A; Deng Y; Yang T; Zhang L; Shao M; Zhou S; Wang C; Liu B
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Nov; 26(11):827-31. PubMed ID: 25399899
[TBL] [Abstract][Full Text] [Related]
37. CD56
Judge CJ; Kostadinova L; Sherman KE; Butt AA; Falck-Ytter Y; Funderburg NT; Landay AL; Lederman MM; Sieg SF; Sandberg JK; Anthony DD
J Leukoc Biol; 2017 Jul; 102(1):171-184. PubMed ID: 28400540
[TBL] [Abstract][Full Text] [Related]
38. Long-term effect on natural killer cells by interferon-α therapy on the outcomes of HCV infection.
Hu X; Jiang Y; Li X; Gao Y; Guo X; Chi X; Yan H; Feng J; Zhong J; Sun B; Shao X; Xiao W; Pan Y; Niu J
J Interferon Cytokine Res; 2014 May; 34(5):366-75. PubMed ID: 24367931
[TBL] [Abstract][Full Text] [Related]
39. Restoration of natural killer cell activity by pegylated interferon-alpha/ribavirin therapy in chronic hepatitis C patient.
Nakamura I; Asano T; Asabe S; Ando M; Sano T; Miyata Y; Taira J; Sugimoto K; Imai Y; Moriyasu F; Imawari M
Hepatol Res; 2015 Jan; 45(1):107-12. PubMed ID: 24606027
[TBL] [Abstract][Full Text] [Related]
40. Increased peripheral CD4
Langhans B; Nischalke HD; Krämer B; Hausen A; Dold L; van Heteren P; Hüneburg R; Nattermann J; Strassburg CP; Spengler U
J Hepatol; 2017 May; 66(5):888-896. PubMed ID: 28040549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
